Loading asset research
Elicio Therapeutics Inc. Common Stock
ELTXNasdaq · USD · StocksQuote as of · Exchange session not verified$2.05
-2.84%
Today
ELTX
Loading 1D prices…
Market cap
$53.9M
Volume
445.6K
52w high
$16.0052w low
$2.02Company profile
Elicio Therapeutics Inc. Common Stock
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Boston, MA, United States
Employees
33
Fiscal year end
1231
CIK
1601485
Session & valuation
Open$2.14
Previous close$2.11
Day high$2.20
Day low$2.02
30-day avg. volume309.2K
Outstanding shares26.3M
Diluted EPS-$2.58
Latest annual period
P/E (trailing)-0.79
P/E (forward)-0.95
Price / book5.66
Beta1.86
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| HYPDHyperion DeFi Inc. Common Stock | $54.2M | $813.5K | -5570.56% | -$9.40 | -3.20% | Hold |
| IMMPImmutep Limited American Depositary Shares | $55M | — | — | -$0.539 | +12.12% | Hold |
| SERSerina Therapeutics Inc. Common Stock | $56.4M | $130K | -14755.38% | -$1.91 | -8.00% | Buy |
| MCRBSeres Therapeutics Inc. Common Stock | $50.3M | $789K | +721.93% | $0.64 | -1.76% | Buy |
| IBOImpact BioMedical Inc. Common Stock | $49.6M | $32K | -36993.75% | -$0.38 | +4.31% | Unrated |